Series C - Karius
Investment Firm
Overview
Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.
Announced Date
May 02, 2024
Funding Type
Series C
Highlights
N/A
Location
N/A
Social
N/A
Investor Lead
Khosla Ventures
Khosla Ventures is a early_stage_venture and late_stage_venture and post_ipo and seed and venture firm.
Gilde Healthcare
Gilde Healthcare is a early_stage_venture and late_stage_venture and private_equity firm.
5AM Ventures
5AM Ventures is a early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.
Participant Investors
7
Round Details and Background
Karius raised $100000000 on 2024-05-02 in Series C
Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.
Company Funding History
5
| Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
|---|---|---|---|---|
| Feb 24, 2020 | 5 | - | 165.0M | |
| May 02, 2024 | 10 | - | 100.0M | |
| Aug 05, 2017 | 8 | - | 59.0M | |
| Sep 22, 2014 | 3 | - | 5.0M |
Recent Activity
News
May 07, 2024
Karius secures $100 million in Series C financing
News
May 05, 2024
Karius Announces $100M Series C Round
News
May 03, 2024
Tech Funding News - US-based Karius targets wider adoption of AI-powered diagnostics with $100M funding
News
May 03, 2024
pitchbook.com - Global VC deals for May 3, 2024
News
May 02, 2024
Venture Capital Access Online - Karius Raises $100M Co-Led by Khosla Ventures, 5AM Ventures and Gilde Healthcare, to Expand Access to Advanced Genomic Diagnostics in Infectious Disease, Addressing Antimicrobial Resistance Crisis
News
May 02, 2024
FinSMEs - Karius Raises $100M in Series C Funding